Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer

被引：0
|
作者：
Besnainou, Hanna [1 ]
Cabel, Luc [2 ]
机构：
[1] Univ Paris Cite, Inst Curie, Dept Oncol Med, 35 Rue Daily, F-92210 Saint-cloud, France
[2] Inst Curie, Dept Oncol Med, 26 rue Ulm, F-75005 Paris, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 04期
关键词：
Breast cancer; Sacituzumab-govitecan; Hormone receptor positive; Antibody-drug conjugate (ADC); Targeted therapies;
D O I：
10.1016/j.bulcan.2023.12.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [1] Sacituzumab govitecan for hormone receptor-positive HER2-negative advanced breast cancer
    Garrigos, Laia
    Camacho, Daniela
    Perez-Garcia, Jose Manuel
    Llombart-Cussac, Antonio
    Cortes, Javier
    Antonarelli, Gabriele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (10) : 949 - 958
  • [2] Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
    Nardin, Simone
    Del Mastro, Lucia
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [3] Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer
    Lopez, M.
    Di Lauro, L.
    Viola, G.
    Foggi, P.
    Conti, F.
    Corsetti, S.
    Sergi, D.
    Botti, C.
    Di Filippo, F.
    Vici, P.
    CLINICA TERAPEUTICA, 2009, 160 (06): : 481 - 488
  • [4] Identification of target kinases whose inhibition enhances antitumor efficacy of sacituzumab-govitecan in metastatic HER2-negative breast cancer
    Oh, Nakyung
    Fuson, Jon A.
    Liu, Huey
    Tripathy, Debu
    Ueno, Naoto T.
    Lee, Jangsoon
    CANCER RESEARCH, 2023, 83 (05)
  • [5] Sacituzumab-govitecan in metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01) : 16 - 16
  • [6] Treatment of HER2-positive and triple-negative Breast Cancer Significant Survival Benefits with Tucatinib and Sacituzumab-Govitecan
    Ruedesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (03) : 144 - 144
  • [7] PROGNOSTIC SIGNIFICANCE OF PgR EXPRESSION IN HORMONE-RECEPTOR POSITIVE, HER2-NEGATIVE, NODE-NEGATIVE BREAST CANCER
    Ono, Makiko
    Hitoshi, Tsuda
    Yoshida, Masayuki
    Shimizu, Chikako
    Kinoshita, Takayuki
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2014, 25
  • [8] Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer
    Lopez-Tarruella, Sara
    Jerez, Yolanda
    Marquez-Rodas, Ivan
    Echavarria, Isabel
    Martin, Miguel
    FUTURE ONCOLOGY, 2017, 13 (24) : 2137 - 2149
  • [9] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer
    Sg, Nithin
    Gogia, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08)
  • [10] Metronomic capecitabine with aromatase inhibitors for patients with metastatic hormone-receptor positive, HER2-negative breast cancer
    Abdelmaksoud, Bader A.
    Toam, Mostafa M.
    Fayed, Alaa A.
    BREAST CANCER MANAGEMENT, 2019, 8 (03)
12345